ArticleHemaSphere2023

Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients With Lymphoproliferative Disorders on BTKi.

Giulia Zamprogna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.